Abstract | BACKGROUND: OBJECTIVE: To describe the clinical effectiveness of ceftaroline fosamil in the treatment of ABSSSI in obese patients [body mass index (BMI) ≥ 30] compared with patients with a normal BMI (18.5 to ≤ 24.9). METHODS: Data were collected at US study centers by randomly ordered chart review. RESULTS: Data from 261 patients with a normal BMI and 690 patients with an obese BMI were collected. The percentage of males was higher in the normal BMI than in the obese category (58.2% and 49.0%, respectively). The mean and median ages at baseline were similar. Most patients (91%) were treated on a general hospital ward, and the mean and median lengths of stay were similar between the 2 groups (approximately 11 days and 7 days, respectively). A total of 73.2% of normal BMI patients and 77.5% of obese patients were discharged to home. Rates of diabetes mellitus were 26.4% in the normal BMI group and 55.1% in the obese group. Methicillin-resistant Staphylococcus aureus was isolated from 26.1% of normal BMI patients and 20.5% of obese patients (16.4% morbidly obese subset). Mean treatment duration for all patients was 5.9 days. Of patients with a normal BMI, 57.5% received ceftaroline fosamil as monotherapy as did 63.3% of obese patients. Clinical success was high in both the normal BMI (85.1%) and the obese (89.0%) groups. CONCLUSION:
Ceftaroline fosamil is an effective treatment option for obese patients with ABSSSI with a similar clinical success rate, mean and median length of stay, and discharge destination to home when compared with normal BMI patients.
|
Authors | John D Evans, George Udeani, Phillip Cole, H David Friedland |
Journal | Postgraduate medicine
(Postgrad Med)
Vol. 126
Issue 5
Pg. 128-34
(Sep 2014)
ISSN: 1941-9260 [Electronic] England |
PMID | 25295657
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Cephalosporins
- ceftaroline fosamil
|
Topics |
- Adolescent
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
(administration & dosage, adverse effects, therapeutic use)
- Cephalosporins
(administration & dosage, adverse effects, therapeutic use)
- Female
- Humans
- Length of Stay
- Male
- Middle Aged
- Obesity
(epidemiology)
- Patient Discharge
- Retrospective Studies
- Sex Factors
- Skin Diseases, Bacterial
(drug therapy, epidemiology)
- Socioeconomic Factors
- United States
- Young Adult
|